Table 3 Joint arthropathies, FISH and treatment modalities in case and control groups
Parameters | Normal group(n = 31) | Osteoporosis group(n = 22) | P |
|---|---|---|---|
FISHa | 16.00(4.53) | 11.82(3.23) | .001 |
Joint countb | 2(1/6) | 4(2/7) | <.001 |
Hip | |||
Normal | 16(30.19%) | 0(0.00%) | <.001 |
Unilateral | 10(18.87%) | 7(13.21%) | |
Bilateral | 5(9.43%) | 15(28.30%) | |
Knee | |||
Normal | 2(3.77%) | 0(0.00%) | <.001 |
Unilateral | 22(41.51%) | 4(7.55%) | |
Bilateral | 7(13.21%) | 18(33.96%) | |
Ankle | |||
Normal | 20(37.74%) | 11(20.75%) | .229 |
Unilateral | 10(18.87%) | 9(16.98%) | |
Bilateral | 1(1.89%) | 2(3.77%) | |
Shoulder | |||
Normal | 26(49.06%) | 18(33.96%) | .419 |
Unilateral | 5(9.43%) | 2(3.77%) | |
Bilateral | 0(0.00%) | 2(3.77%) | |
Elbow | |||
Normal | 25(47.17%) | 14(26.42%) | .118 |
Unilateral | 6(11.32%) | 7(13.21%) | |
Bilateral | 0(0.00%) | 1(1.89%) | |
Treatment | .563 | ||
On-demand Treatment | 1(1.89%) | 2(3.77%) | |
Long-term regular tertiary prophylaxis | 30(56.60%) | 20(37.74%) | |
Age at start(years)a | 35.15(5.76) | 36.42(9.61) | .585 |
Therapy time(month)a | 29.33(18.29) | 33.50(18.71) | .438 |
Prophylactic dose(IU/Kg)a | 20.69(9.55) | 25.77(10.09) | .078 |